22/04/13
Announcement of Joint Research Agreement Regarding New Therapeutic Approach against Cardiovascular Diseases
21/09/03
Announcement of New Chief Technology Officer (CTO): Pro. Yoshiki Sawa
21/03/16
Private Placement of New Shares
20/12/04
